Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Cynthia A. Bossie"'
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2008, Iss Issue 5, Pp 949-958 (2008)
Ibrahim Turkoz, Cynthia A Bossie, Bryan Dirks, Carla M CanusoOrtho-McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USAAbstract: Direct and indirect effects of the new psychotropic paliperidone extended-release (paliperidone ER) tablets on neg
Externí odkaz:
https://doaj.org/article/a85737ed2de249969bd1778a236c12c1
Publikováno v:
Journal of psychosocial nursing and mental health services. 57(11)
Publikováno v:
The Journal of Nervous and Mental Disease
Data from a multiphase schizoaffective disorder study (NCT01193153) were used to examine the effects of paliperidone palmitate once-monthly (PP1M) by subjects' illness duration, defined as recent onset (≤5 years since first psychiatric diagnosis; n
Publikováno v:
Journal of Affective Disorders. 193:381-390
Background Patients with schizoaffective disorder (SCA) experience complicated interplays of psychotic, depressive, and manic symptoms. Paliperidone extended-release (pali ER) tablets have been shown to be efficacious in these patients, but treatment
Publikováno v:
Early Intervention in Psychiatry. 12:55-65
Aim Long-acting injectable antipsychotics (APs) are not well studied in recent-onset schizophrenia. This exploratory analysis of a study designed to reflect real-world schizophrenia, as defined by patients, interventions and outcomes, compared relati
Publikováno v:
International Clinical Psychopharmacology
Trial design characteristics related to the explanatory : pragmatic spectrum may contribute toward the inconsistent results reported in studies comparing long-acting injectable (LAI) versus daily oral antipsychotic (AP) treatments in schizophrenia. A
Autor:
David Hough, Cynthia A. Bossie, Srihari Gopal, Isaac Nuamah, Dong-Jing Fu, Haiyan Xu, J. A. Burón, Adam Savitz
Publikováno v:
International Journal of Clinical Practice
Summary Background To assess the tardive dyskinesia (TD) rate in studies of once-monthly long-acting injectable (LAI) paliperidone palmitate (PP) and once-daily oral paliperidone extended release (Pali ER). Methods Completed schizophrenia and bipolar
Publikováno v:
Psychopathology. May2008, Vol. 41 Issue 4, p264-270. 7p.
Publikováno v:
Innovations in clinical neuroscience. 12(11-12)
This analysis evaluates improvement in symptoms of depression in patients with schizoaffective disorder administered oral paliperidone extended-release by accounting for the magnitude of direct and indirect (changes in negative and positive symptoms
Autor:
Nina R. Schooler, Ibrahim Turkoz, Carla M Canuso, Jean-Pierre Lindenmayer, Cynthia A. Bossie, Colette Kosik-Gonzalez, Jennifer Carothers
Publikováno v:
The Journal of Clinical Psychiatry. 71:587-598
Objective This study was designed to assess efficacy and safety of paliperidone extended-release (ER) in patients with schizoaffective disorder. Method A randomized, 6-week, double-blind, placebo-controlled study was conducted. Subjects with a Struct